J. Casper

1.5k citations

41 papers · 970 indexed · h-index 17

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment

Papers in ⓘ

Hematology 19
- Hematopoietic Stem Cell Transplantation 13
- Multiple Myeloma Research and Treatments 5
Surgery 14
- Testicular diseases and treatments 14

Co-authors: Hans‐Joachim Schmoll (18 shared papers)Carsten Bokemeyer (7 shared papers)A. Harstrick (6 shared papers)Mathias Freund (12 shared papers)Theresa Dunn (4 shared papers)Lothar Kanz (4 shared papers)J. Beyer (3 shared papers)A. Gerl (2 shared papers)
Journals: Bone Marrow Transplantation (7 papers)Journal of Clinical Oncology (4 papers)Investigational New Drugs (3 papers)International Journal of Andrology (3 papers)European Journal of Cancer (2 papers)
Partner nations: Germany United States Finland

In The Last Decade

J. Casper

41 papers receiving 950 citations

Peers

Countries citing papers authored by J. Casper

Since Specialization

Citations

This map shows the geographic impact of J. Casper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Casper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Casper more than expected).

Fields of papers citing papers by J. Casper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Casper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Casper. The network helps show where J. Casper may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Casper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Casper Line = papers co-authored together J. Casper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Gemcitabine in Patients With Relapsed or Cisplatin-Refractory Testicular Cancer Journal of Clinical Oncology ·Carsten Bokemeyer, A. Gerl, P. Schöffski, A. Harstrick, N. Niederle, J. Beyer, J. Casper, Hans‐Joachim Schmoll, Lothar Kanz	1999	104
2	Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ Cell Cancer Journal of Clinical Oncology ·Oliver Rick, Carsten Bokemeyer, J. Beyer, J.T. Hartmann, N. Schwella, D. Kingreen, S. Neureither, Bernd Metzner, J. Casper, H. Wandt, Frank Hartmann, Hans‐Joachim Schmoll, G. Derigs, A. Gerl, Wolfgang E. Berdel, Lothar Kanz, W. Siegert	2001	98
3	Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications Bone Marrow Transplantation ·Dietrich W. Beelen, Rudolf Trenschel, J. Casper, Mathias Freund, Ralf A. Hilger, M. E. Scheulen, Nadežda Basara, A. A. Fauser, Bernd Hertenstein, H. A. Mylius, Joachim Baumgart, Uwe Pichlmeier, J. Hahn, Ernst Holler	2004	84
4	Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. Journal of Clinical Oncology ·A. Harstrick, Hans‐Joachim Schmoll, Hans‐Joachim Wilke, C.H. Köhne-Wömpner, M. Stahl, C. Schöber, J. Casper, L Bruderek, Carsten Bokemeyer	1991	74
5	Comparative cytotoxicity of oxaliplatin and cisplatin in non-seminomatous germ cell cancer cell lines Investigational New Drugs ·Theresa Dunn, Hans‐Joachim Schmoll, Viktor Grünwald, Victoria Bokemeyer, J. Casper	1997	74
6	Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept Bone Marrow Transplantation ·Daniel Wolff, V Roessler, Beate Steiner, Stefan Wilhelm, Volker Weirich, Julia Brenmoehl, Malte Leithaeuser, Nicole Hofmeister, Christian Junghanß, J. Casper, G. Hartung, Ernst Holler, Mathias Freund	2005	67
7	Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease Bone Marrow Transplantation ·Daniel Wolff, Stefan Wilhelm, J. Hahn, Chiara Gentilini, Inken Hilgendorf, Beate Steiner, Christoph Kahl, Christian Junghanß, G. Hartung, J. Casper, L. Uharek, Ernst Holler, Mathias Freund	2006	42
8	Cell lines of human germinal cancer International Journal of Andrology ·J. Casper, Hans‐Joachim Schmoll, U. Schnaidt, Christa Fonatsch	1987	37
9	Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study. PubMed ·John Graham‐Pole, BM Camitta, J. Casper, Gerald J. Elfenbein, S. Gross, RH Herzig, P. Koch, Donald H. Mahoney, R Marcus, Luz Muñoz	1988	35
10	Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma Bone Marrow Transplantation ·Martin Schmidt‐Hieber, Igor Wolfgang Blau, Rudolf Trenschel, Reinhard Andreesen, Gernot Stuhler, H. Einsele, Lothar Kanz, Ulrich Keilholz, Olga Marinets, Dietrich W. Beelen, AA Fauser, Liisa Volin, Tapani Ruutu, L. Uharek, Thomas Fietz, Wolfgang Knauf, W. Hopfenmüller, E. Thiel, Mathias Freund, J. Casper	2007	31
11	Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation Annals of Hematology ·Christoph Kahl, M. Leith x E user, Daniel Wolff, Beate Steiner, G. Hartung, J. Casper, Mathias Freund	2002	26
12	Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell linesin vivo andin vitro Cancer ·A. Harstrick, J. Casper, R. Guba, H. Wilke, H. Poliwoda, Hans‐Joachim Schmoll	1989	26
13	Analysis of the MHC Class I Antigen Presentation Machinery in Human Embryonal Carcinomas: Evidence for Deficiencies in TAP, LMP and MHC Class I Expression and their Upregulation by IFN‐γ Scandinavian Journal of Immunology ·Barbara Seliger, Theresa Dunn, A. SCHWENZER, J. Casper, Christian G. Huber, Hans‐Joachim Schmoll	1997	23
14	Cell surface lectins of transplantable human teratocarcinoma cells: purification of a new mannan-specific endogenous lectin. PubMed ·Hans‐Joachim Gabius, Reinhild Engelhardt, J. Casper, D Reile, Stephanie Schumacher, Hans‐Joachim Schmoll, Gerhart Graupner, F. Cramer	1985	21
15	Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor. PubMed ·Lubomir Arseniev, H J Tischler, Karin Battmer, I. Südmeier, J. Casper, Hartmut Link	1994	20
16	Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation. PubMed ·J. Casper, Wolfgang Knauf, IW Blau, Tapani Ruutu, Liisa Volin, H. Wandt, K. Schäfer-Eckart, Jerzy Hołowiecki, Sebastian Giebel, J Aschan, A Zander, Nicolaus Kröger, Gottfried Doelken, M. Freund	2004	19
17	High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation Bone Marrow Transplantation ·Michael Koenigsmann, Martin Mohren, Kathleen Jentsch‐Ullrich, Anne Franke, E. Becker, M.U. Heim, Mathias Freund, J. Casper	2004	18
18	Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation Annals of Oncology ·Bernd Metzner, Christiane Pott, Thomas Müller, Wolfgang Gebauer, J. Casper, Doris Kraemer, Bernd Rosien, Silke Schumann‐Binarsch, Ruth Thole, C.-H. Köhne	2013	16
19	Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression. PubMed ·Christian Junghanß, Michaela Waak, A. Knopp, H.-D. Kleine, Günther Kundt, Malte Leithäuser, Inken Hilgendorf, Daniel Wolff, J. Casper, Mathias Freund	2005	13
20	A Phase II study of high dose tamoxifen in progressive, metastatic renal cell Annals of Oncology ·M. Stahl, H. Wilke, Hans‐Joachim Schmoll, Ch. Schöber, H. Diedrich, J. Casper, Mathias Freund, H. Poliwoda	1992	13

About J. Casper

J. Casper is a scholar working on Hematology, Surgery, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 41 papers that have together received 970 indexed citations. Recurring topics across this work include Testicular diseases and treatments (14 papers), Hematopoietic Stem Cell Transplantation (13 papers), Cancer therapeutics and mechanisms (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Neuroblastoma Research and Treatments (5 papers). The work is most often cited by research in Hematology (395 citations), Reproductive Medicine (120 citations), Transplantation (37 citations), Neurology (171 citations) and Immunology (179 citations). J. Casper has collaborated with scholars based in Germany, United States and Finland. Frequent co-authors include Hans‐Joachim Schmoll, Carsten Bokemeyer, A. Harstrick, Mathias Freund, Theresa Dunn, Lothar Kanz, J. Beyer, A. Gerl, Daniel Wolff and Viktor Grünwald. Their work appears in journals such as Bone Marrow Transplantation, Journal of Clinical Oncology, Investigational New Drugs, International Journal of Andrology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact